Cart
sales@molnova.com
CDK9-IN-2
CAS No. 1269815-17-9
CDK9-IN-2( CDK9 inhibitor II )
Catalog No. M11131 CAS No. 1269815-17-9
CDK9-IN-2 is a potent and selective CDK9 inhibitor with IC50 of <8 nM, example 4 in patent WO2011026917A1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 2MG | 47 | In Stock |
|
| 5MG | 88 | In Stock |
|
| 10MG | 141 | In Stock |
|
| 25MG | 272 | In Stock |
|
| 50MG | 389 | In Stock |
|
| 100MG | 551 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1097 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCDK9-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDK9-IN-2 is a potent and selective CDK9 inhibitor with IC50 of <8 nM, example 4 in patent WO2011026917A1.
-
DescriptionCDK9-IN-2 is a potent and selective CDK9 inhibitor with IC50 of <8 nM, example 4 in patent WO2011026917A1.
-
In Vitro——
-
In Vivo——
-
SynonymsCDK9 inhibitor II
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1269815-17-9
-
Formula Weight363.8138
-
Molecular FormulaC18H19ClFN3O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCOC1=C(C=C(C=C1)F)C2=CC(=NC=C2Cl)NC(=O)C3CCCNC3
-
Chemical Name3-Piperidinecarboxamide, N-[5-chloro-4-(5-fluoro-2-methoxyphenyl)-2-pyridinyl]-, (3R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Keith B Pfister, et al. Heteroaryl compounds as kinase inhibitors. 2011, WO2011026917A1.
molnova catalog
related products
-
Butyrolactone I
Butyrolactone I is an ATP-competitive inhibitor of CDK and cdc2 kinase family.
-
Olomoucine
A potent, ATP-competetive CDKs inhibitor with IC50 of 7, 7, 7, 3 uM for Cdc2/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, and Cdk/p35 kinase; also inhibits ERK1/MAP kinase (IC50=25 uM).
-
Furanodiene
Furanodiene has anti-inflammatory and antioxidant activities, it is active against gram-positive bacteria and Candida albicans.The in vitro effects of Furanodiene were examined on two human breast cancer cell lines, MCF-7 and MDA-MB-231 cells.
